AMRI acquires Cedarburg Pharmaceuticals $41 million improving AMRI revenue
X
Waste Management Expo 2020 MAR 12&13 BIEC, Bengaluru, India

AMRI completes acquisition of Cedarburg Pharmaceuticals

10:39 AM, 7th April 2014
MRI acquires Cedarburg Pharmaceuticals

ALBANY, US: AMRI has completed the previously announced acquisition of Cedarburg Pharmaceuticals, Inc. Cedarburg, is a contract developer and manufacturer of technically complex active pharmaceutical ingredients (API) for both generic and branded customers. Total consideration paid was $41 million, including assumption of certain liabilities. AMRI financed the transaction with cash on hand. The acquisition is expected to add between $13 and $14 million to AMRI’s revenue in 2014.

The transaction is consistent with AMRI’s strategy to be the preeminent supplier of custom and complex drug development services and product to both the branded and generic pharmaceutical industry. Customers will benefit from access to a greater breadth of resources, including development of complex API, expanded scale-up capabilities and large scale manufacturing in lower cost environments.

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Sherwin-Williams terminates the acquisition of Comex Mexico

CLEVELAND, US: Sherwin-Williams Co, the largest US paint retailer, terminated its agreement to acquire the Mexican operations of Consorcio Comex SA af ...

Read more
Newly engineered bacterium to synthesize rocket fuel

GEORGIA, US: Researchers at the Georgia Institute of Technology and the Joint BioEnergy Institute have engineered a bacterium to synthesize pinene, a ...

Read more
Flowers of tobacco plant may destroy cancer cells

SYDNEY, AUSTRALIA: Tobacco has been associated with and much maligned for causing cancers. Researchers have now found that the tobacco plant’s d ...

Read more
Creating small peptide chain may revolutionize study of enzymes

SYRACUSE, US: Chemists at Syracuse University have, for the first time, created enzyme-like activity using peptides that are only seven amino acids lo ...

Read more
Sun Pharmaceutical acquires Ranbaxy for $3.2 billion

MUMBAI/ GURGAON, INDIA: Sun Pharmaceutical Industries Ltd will buy Ranbaxy Laboratories Ltd in a $3.2 billion all-share deal. Ranbaxy, India’s b ...

Read more
Medical device inside the body to dissolve completely when triggered

AMES, US: A medical device can harmlessly melt away inside a person’s body, once its job is done. Or, a military device could collect and send i ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X